Shots:

• The companies collaborated to form JV to develop- manufacture- and commercialize biosimilars for a global market
• The collaboration will utilize Cipla and Kemwell’s strengths for product development- clinical development- regulatory filings- manufacturing- and commercialization of biopharma products
• Cipla’s respiratory expertise & Kemwell’s biologics will combine to accelerate the products in the market

Ref: Biogen | Image: Stat News